Results of the Annual General Meeting
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), Imagion Biosystems Limited advises the results its 2019 Annual General
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001 (Cth), Imagion Biosystems Limited advises the results its 2019 Annual General
Imagion Biosystems announces the transcript of the Chairman’s address to shareholders at the Annual General Meeting. Read the transcript.
Imagion Biosystems Limited is pleased to share news of research published by collaborators from the University of Sydney demonstrating that Imagion’s iron oxide nanoparticles enable
Imagion Biosystems Limited announces that its Chief Financial Officer, Brian Conn, will be leaving the Company effective 1st August 2020. Brian has served as a
Imagion Biosystems Limited (ASX: IBX) is pleased to announce it has become a member of the Nanosystems Engineering Research Center at Boston University, where researchers
The Annual General Meeting (AGM) of Imagion Biosystems Limited (the Company) will be held virtually on Wednesday, 22 July 2020 at 11.00am (Melbourne time). In
We recently announced plans to conduct our first in-human study for MagSense in Australia later this year. In this Market Herald interview, watch IBX CEO Bob
Imagion Biosystems has made the attached Appendix 3Y announcements in relation to change of Directors interest notice. Read Appendix 3Y — Change in Director’s Interest
You can also register to watch the entire Zoom webcast on-demand by clicking here
Imagion Biosystems Limited advises that the 200,000 Performance Rights issued to Directors of the Company under the Company Long-term Incentive Plan on 14 June 2018,
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance
We have temporarily suspended our nanoparticle operations. Please revisit us in the future. We apologize for the inconvenience. Any questions, please email: info@imagionbio.com Dismiss